In working with many various organizations to undertake resilient medical trial methods, one factor has change into clear to me: the directive should come from the C-suite.
Thoughts the (expertise) hole
In working with many various organizations to undertake resilient medical trial methods, one factor has change into clear to me: the directive should come from the C-suite.
